D Dimer Testing Market Outlook and Analysis Through 2024-2033: Evaluating Growth Opportunities

The d dimer testing market size has grown strongly in recent years. It will grow from $1.38 billion in 2023 to $1.46 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to emergence of thrombosis research, improvements in laboratory techniques, clinical validation of d-dimer as a marker, shift in diagnostic protocols.

The d dimer testing market size is expected to see steady growth in the next few years. It will grow to $1.77 billion in 2028 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing geriatric population, growth in point-of-care testing (poct), integration with risk assessment algorithms, increased awareness and education campaigns, regulatory guidance and standardization. Major trends in the forecast period include biomarker combinations for enhanced diagnosis, focus on rapid and accurate results, d-dimer testing in covid-19 management, remote monitoring and home-based testing kits, continuous monitoring and serial testing.

Market Overview -
D-dimer testing refers to laboratory blood testing that measures the d-dimer level in the bloodstream. D-dimer is a protein fragment produced when a blood clot breaks down in the body. The test is primarily used to help diagnose or rule out the presence of blood clots, particularly in conditions such as deep vein thrombosis (DVT) or pulmonary embolism (PE).

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=12341&type=smp

Cancer Prevalence Fuels Expansion Of The D-Dimer Testing Market
The increasing prevalence of cancer is expected to propel the growth of the d-dimer testing market going forward. Cancer is a category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. D-dimer testing is primarily used to help diagnose, monitor, and treat cancer patients and assess the risk of blood clot formation. It monitors thrombotic events in various clinical settings. For instance, in January 2022, according to research published by the American Cancer Society, a US-based health organization, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in the US in 2022. It is about 1,670 fatalities each day. Therefore, the increasing prevalence of cancer is driving the growth of the d-dimer testing market.

Competitive Landscape -
Major companies operating in the d dimer testing market report are Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson And Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Sekisui Diagnostics LLC, Personalabs, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., AdvaCare Pharma USA, UCP Biosciences Inc., Unbound Medicine Inc., AccuBioTech Co Ltd., Response Biomedical Corporation.

Strategic Partnerships Drive Advancements In The D-Dimer Testing Market
Major companies operating in the d-dimer testing market are adopting a strategic partnership approach to gain exclusive rights to d-dimer testing solutions and gain a competitive edge in the market. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in March 2022, SphingoTec GmbH, a Germany-based biotechnology company, partnered with Rivaara Labs Pvt Ltd., an India-based medical laboratory and healthcare company. Under this partnership, Rivaara gains exclusive rights to market and distribute SphingoTec's point-of-care tests featuring innovative biomarkers in the Indian subcontinent. These biomarkers encompass proenkephalin (penKid) for kidney function assessment, bioactive adrenomedullin (bio-ADM) for endothelial function evaluation, and dipeptidyl peptidase 3 (DPP3) as a biomarker for cardiac depression. These pioneering markers are supplemented by commonly utilized parameters such as procalcitonin, troponin, D-dimer, NT-proBNP, and TSH.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

Key Segments -

The d dimer testing market covered in this report is segmented -
1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests
2) By Product: Analyzers, Reagents And Consumables
3) By Method: Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays, Other Testing Method
4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Application
5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-User

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

"Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model "

"Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps"

This release was published on openPR.